Ferah TUNCEL, Aslıhan ALPASLAN DUMAN, Deniz ATEŞ ÖZDEMİR, Alp USUBÜTÜN

Novel immunohistochemical marker in the differential diagnosis of sex cord-stromal tumors: SF-1

Aim: Sex cord-stromal tumors are relatively uncommon tumors which constitute approximately 8% of all primary ovarian neoplasms. Morphologic differentiation of non-SCST from SCSTs can be challenging due to microscopic overlap. Immunohistochemistry is beneficial in challenging cases. Inhibin and calretinin have limited sensitivity and specificity, a more sensitive marker is required. SF-1 is known as a promising immunohistochemical marker in the differentiation of SCST from non-SCST ovarian tumors. For this purpose, various non-SCSTs (metastatic and non-metastatic) having morphologic overlap with SCSTs, and multiple SCSTs were stained with SF-1 antibody to elucidate its importance in morphologically challenging cases. Materials and Methods: Twenty-three SCST, 40 non-SCSTs, and an ectopic adrenal tissue were stained with SF-1, and also the percentage and the intensity were scored. SF-1 immunoreactivity was seen in all 23 SCST with varying degrees of intensity and percentage. In contrast, non-SCSTs were negative in all regarding to SF-1. Ectopic adrenal gland tissue and ovarian stroma are positive as non-tumoral lesions. Results: In our series, SF-1 immunoreactivity was seen in all 23 SCST and ectopic adrenal tissue with varying degrees of intensity and diffuseness. In contrast, non-SCSTs were all negative concerning SF-1. In addition; we observed nuclear positivity with SF-1 in 15-75% of the sclerosing stromal tumor cells, whereas inhibin and calretinin were negative in all 4 cases. Conclusion: Our data shows that SF-1 is a nuclear, reliable and surrogate marker for all SCSTs, and can be used routinely.

PDF

___

1. Al-Agha OM, Huwait HF, Chow C, et al. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 2011;35:484- 94.
2. Stewart CJ, Alexiadis M, Crook ML, Fuller PJ. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cordstromal tumors. Hum Pathol 2013;44:2774-81.
3. Zhao C, Barner R, Vinh TN, et al. SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian sertoli cell tumor. Int J Gynecol Pathol 2008;27:507-14.
4. Rishi M, Howard LN, Bratthauer GL, Tavassoli FA. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 1997;21:583-9.
5. Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alphainhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases. Am J Surg Pathol 2002;26:1477-83.
6. Yalcin Comert HS, Eyuboglu I, Ersoz S, Aet al. Ovarian masses in children: A single center’s experience. Ann Med Res 2020;27:1465-8.
7. Cevik M, Boleken ME. Characteristics and Approach of Ovarian Masses in Children: Series of 34 Cases. Van Med J 2013;20:57-61.
8. Haroon S, Zia A, Idrees R, et al. Clinicopathological spectrum of ovarian sex cord-stromal tumors; 20 years’ retrospective study in a developing country. J Ovarian Res 2013;6:87.
9. Shim SH, Kim DY, Lee SW, et al. Laparoscopic management of early-stage malignant non-epithelial ovarian tumors: surgical and survival outcomes. Int J Gynecol Cancer 2013; 23:249-55.
10. Jung SE, Rha SE, Lee JM, et al. CT and MRI findings of sex cord-stromal tumor of the ovary. Am J Roentgenol 2005;85:207-15.
11. Rathore R, Arora D, Agarwal S, Sharma S. Correlation of FOXL2 with Inhibin and Calretinin in the Diagnosis of Ovarian Sex Cord Stromal Tumors. Turkish J of Pathology 2016;33:121-8.
12. Deavers MT, Malpica A, Liu J, et al. Ovarian sex cordstromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 2003;16:584-90.
13. McCluggage WG, McKenna M, McBride HA. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cordstromal tumors. Int J Gynecol Pathol 2007;26:322-7.
14. Zhao C, Bratthauer GL, Barner R, Vang R. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor. Am J Surg Pathol 2007;31:1378-86.
15. Zhao C, Vinh TN, McManus K, et al. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cordstromal tumors. Am J Surg Pathol 2009;33:354-66.
16. D'Angelo E, Mozos A, Nakayama D, Espinosa I, Catasus L, Munoz J et al. Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary. Mod Pathol 2011;24:1360-7.
17. Georges A, Auguste A, Bessiere L, Vanet A, Todeschini AL, Veitia RA. FOXL2: a central transcription factor of the ovary. J Mol Endocrinol 2013;52:R17-33.
18. Goulvent T, Ray-Coquard I, Borel S, Haddad V, Devouassoux-Shisheboran M, Vacher-Lavenu MC et al. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Histopathology 2016;68:279-85.
19. Kommoss S, Gilks CB, Penzel R, Herpel E, Mackenzie R, Huntsman D, et al. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Histopathology 2014;64:380-8.
20. Sangoi AR, McKenney JK, Brooks JD, Higgins JP. Evaluation of SF-1 expression in testicular germ cell tumors: a tissue microarray study of 127 cases. Appl Immunohistochem Mol Morphol 2013;21:318-21.
21. Irving JA, Lee CH, Yip S, Oliva E, McCluggage WG, Young RH. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and beta-catenin Nuclear Expression and CTNNB1 Mutations. Am J Surg Pathol 2015;39:1420-6.
22. Stewart CJ, Crook M, Tan A. SF1 immunohistochemistry is useful in differentiating uterine tumours resembling sex cord-stromal tumours from potentialhistological mimics. Pathology 2016;48:434-40.
23. Goyal A, Masand RP, Roma AA . Value of PAX-8 and SF-1 Immunohistochemistry in the Distinction Between Female Adnexal Tumor of Probable Wolffian Origin and its Mimics. Int J Gynecol Pathol 2016;35:167-75.
24. Bai S, Wei S, Ziober A, Yao Y, Bing Z (2013) SALL4 and SF-1 are sensitive and specific markers for distinguishing granulosa cell tumors from yolk sac tumors. Int J Surg Pathol 2013;21:121-5.